MedTrace Logo

Moderate Alcohol Intake Among Patients With Type 2 Diabetes

NCT00295334 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2025-06-24

Study results available
· View outcomes & findings →

Summary

Our specific aim is to explore the effect of moderate alcohol intake on parameters of glycemic index and lipid profile among patients with type 2 diabetes.

Conditions

Interventions

DRUG

alcohol

Sponsors & Collaborators

  • The Israeli Diabetes Research Group

    collaborator UNKNOWN

  • Hadassah Medical Organization

    collaborator OTHER

  • Soroka University Medical Center

    collaborator OTHER

  • Julio Vainstein, Wolfson Medical Center, Holon, Israel

    collaborator UNKNOWN

  • Tishbi Wines, Israel and Admiral Wine Imports, US

    collaborator UNKNOWN

  • Harvard University

    collaborator OTHER

  • Iris Shai

    lead OTHER

Principal Investigators

  • Iris Shai, RD PhD · Ben-Gurion University of the Negev

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00295334 on ClinicalTrials.gov